Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment

被引:112
作者
Boudreau, N
Myers, C
机构
[1] Univ Calif San Francisco, Surg Res Lab, Dept Surg, San Francisco, CA 94143 USA
[2] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA
关键词
angiogenesis; hypoxia-inducible factor 1 alpha (HIF-1 alpha); integrins; vascular endothelial growth factor (VEGF);
D O I
10.1186/bcr589
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Growth and progression of breast cancers are accompanied by increased neovascularization ( angiogenesis). A variety of factors, including hypoxia and genetic changes in the tumor cells, contribute to increased production of angiogenic factors. Furthermore, cells within the activated tumor stroma also contribute to the increase in production of vascular endothelial growth factor and other angiogenic factors, including basic fibroblast growth factor and platelet-derived growth factor. The contribution of the microenvironment to tumor-induced angiogenesis is underscored by findings that breast tumors implanted into different tissue sites show marked differences in the extent and nature of the angiogenic response. These findings have important implications for designing anti-angiogenic therapies.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 62 条
[21]   Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes - Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia [J].
Gerber, HP ;
Condorelli, F ;
Park, J ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (38) :23659-23667
[22]   VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism [J].
Gerber, HP ;
Malik, AK ;
Solar, GP ;
Sherman, D ;
Liang, XH ;
Meng, G ;
Hong, K ;
Marsters, JC ;
Ferrara, N .
NATURE, 2002, 417 (6892) :954-958
[23]   Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions [J].
Greb, RR ;
Maier, I ;
Wallwiener, D ;
Kiesel, L .
BRITISH JOURNAL OF CANCER, 1999, 81 (02) :225-231
[24]  
Guidi AJ, 1997, CANCER, V80, P1945, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1945::AID-CNCR11>3.0.CO
[25]  
2-Y
[26]   Endostatin is a potential inhibitor of Wnt signaling [J].
Hanai, J ;
Gloy, J ;
Karumanchi, SA ;
Kale, S ;
Tang, JA ;
Hu, GA ;
Chan, B ;
Ramchandran, R ;
Jha, V ;
Sukhatme, VP ;
Sokol, S .
JOURNAL OF CELL BIOLOGY, 2002, 158 (03) :529-539
[27]   Openings between defective endothelial cells explain tumor vessel leakiness [J].
Hashizume, H ;
Baluk, P ;
Morikawa, S ;
McLean, JW ;
Thurston, G ;
Roberge, S ;
Jain, RK ;
McDonald, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1363-1380
[28]   Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment [J].
Hattori, K ;
Heissig, B ;
Wu, Y ;
Dias, S ;
Tejada, R ;
Ferris, B ;
Hicklin, DJ ;
Zhu, ZP ;
Bohlen, P ;
Witte, L ;
Hendrikx, J ;
Hackett, NR ;
Crystal, RG ;
Moore, MAS ;
Werb, Z ;
Lyden, D ;
Rafii, S .
NATURE MEDICINE, 2002, 8 (08) :841-849
[29]   Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand [J].
Heissig, B ;
Hattori, K ;
Dias, S ;
Friedrich, M ;
Ferris, B ;
Hackett, NR ;
Crystal, RG ;
Besmer, P ;
Lyden, D ;
Moore, MAS ;
Werb, Z ;
Rafii, S .
CELL, 2002, 109 (05) :625-637
[30]   Tumor regression by targeted gene delivery to the neovasculature [J].
Hood, JD ;
Bednarski, M ;
Frausto, R ;
Guccione, S ;
Reisfeld, RA ;
Xiang, R ;
Cheresh, DA .
SCIENCE, 2002, 296 (5577) :2404-2407